Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol versus lidocaine + propofol sedation for bronchoscopy
IRCT20160307026950N57Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of propofol and lidocaine (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Blood pressure, Arterial oxygen saturation and 2 more. Started Feb 2024; status: completed.
02
Drugs
propofollidocaine
Beyond the preview
Go deeper on IRCT20160307026950N57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N57.